检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

XPO1 Overexpression Is a Mechanism of Resistance to Eprenetapopt and 5-Azacitidine Therapy That Can be Therapeutically Exploited for the Treatment of TP53 Mutated Myeloid Malignancies

Traci L. Kruer,Ariel Quintana,Meghan Ferrall-Fairbanks,Ling Zhang,Hannah Newman,Amy F McLemore,Qin Yang, Nana Bencrentsil,Rami S. Komrokji,Sana Chaudhry,Tulasigeri M Totiger,Maria Ken E. Figueroa,Justin Taylor,David A. Sallman,Eric Padron

Blood（2022）

引用 1|浏览17
暂无评分
关键词
myeloid malignancies,eprenetapopt,treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要